Global Ursodeoxycholic Acid API Market Strategic Research Report

Scope of the Report

The global Ursodeoxycholic Acid API market size is predicted to grow from US$ 606 million in 2025 to US$ 1,108 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.

Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. In addition, the CAS number is 128-13-2.

The growing prevalence of liver diseases, such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and certain forms of liver cirrhosis, serves as a significant driver for the Ursodeoxycholic Acid (UDCA) API market. As more individuals are diagnosed with these conditions due to improved medical awareness and diagnostic techniques, the demand for effective treatments like UDCA increases. UDCA has demonstrated efficacy in managing and alleviating symptoms of these liver diseases, positioning it as a valuable therapeutic option. The rising global burden of liver disorders, often associated with factors like aging and lifestyle changes, provides a sustained demand for UDCA API as a key component in manufacturing medications to address these conditions.

However, the UDCA API market faces several challenges, with regulatory hurdles and price pressures being significant constraints. The stringent approval requirements and the need for high-quality production standards in API manufacturing can delay the market entry of new players and increase operational costs. Furthermore, with the increasing production of generic UDCA products, competition has intensified, leading to a decrease in profit margins for manufacturers of branded UDCA drugs. Another challenge is the limited scope of UDCA applications, as the drug is effective primarily for a specific set of liver conditions, limiting its broader market appeal. Additionally, supply chain disruptions and raw material price fluctuations for manufacturing UDCA can affect the availability and cost-effectiveness of APIs, further complicating market dynamics.

Global key players of Ursodeoxycholic Acid API include ICE, Daewoong Chemical, PharmaZell GmbH and Zhongshan Bailing, etc. The top five players hold a share about 81%.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ursodeoxycholic Acid API market?

What factors are driving Ursodeoxycholic Acid API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ursodeoxycholic Acid API market opportunities vary by end market size?

How does Ursodeoxycholic Acid API break out by Type, by Application?

This report presents a comprehensive overview of the global Ursodeoxycholic Acid API market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Chemical Method
• Enzyme Method

Segment by Diseases

• Bile Disorders
• Liver Diseases
• Gallstones
• Other

Segment by Grade

• US Grade
• EU Grade
• Both

Segment by Application

• Tablets
• Capsules
• Suspensions

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Ursodeoxycholic Acid API market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Tablets, Capsules, Suspensions evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact